Latest Partnerships News

Mont Royal Resources has finalized its merger with Commerce Resources, creating a dual-listed critical metals company focused on advancing one of North America’s largest rare earth deposits in Québec. Backed by a fresh A$10 million capital raise and a seasoned leadership team, Mont Royal is poised to become a key player in the global rare earths market.

Kula Gold reports a maiden inferred tailings resource at Mt Palmer, confirms a significant niobium anomaly in Malawi, and completes a $2.5 million strategic placement to Forrestania Resources.

ABx Group is set to begin drilling at its T8 Rare Earths discovery in northern Tasmania, targeting expansion of high-grade dysprosium and terbium mineralisation critical for advanced technologies.

Starpharma has secured a $5.5 million upfront payment from Genentech as part of a new collaboration to develop dendrimer-drug conjugates targeting cancer therapies. The partnership includes potential milestone payments exceeding half a billion dollars and tiered royalties.

Resolution Minerals is fast-tracking its downstream antimony strategy in Idaho, aiming to become a key US supplier while preparing for a Nasdaq listing with Tribeca Capital's support.

Vitasora Health has received $2.43 million from a cornerstone investor, advancing its $11 million capital raise and reinforcing its path to profitability by Q4 FY2026. The company’s expanding US partnerships and technology investments signal growing market confidence.

Element 25 has appointed Altris Engineering to lead the AU$64.8 million expansion of its Butcherbird manganese mine, a move that underpins its strategy to supply high-purity battery materials to the US electric vehicle market.

ACDC Metals reports compelling mineralogy results from its Goschen Central project, highlighting elevated rare earth element grades that reinforce its economic potential. The announcement coincides with strategic momentum from the Australia-US Critical Minerals Framework, positioning the project as a key player in global supply chains.

Island Pharmaceuticals secures FDA confirmation that regulatory feedback on Galidesivir’s approval pathway will arrive on schedule, underscoring the drug’s strategic importance amid US government disruptions.

Renascor Resources reports steady progress on its Purified Spherical Graphite demonstration plant in Adelaide, backed by a $5 million government grant, aiming to challenge China’s dominance in battery materials.

TZ Limited has turned down a non-binding offer from Quadient SA for its US Smart Locker subsidiary, Telezygology Inc., citing undervaluation and strategic importance of its Data Centre Security division. The company is now initiating a strategic review to explore future options for the business.

BlinkLab Limited has completed its U.S. pilot study for the Dx 1 smartphone-based autism diagnostic device, demonstrating strong accuracy and securing FDA alignment for its pivotal trial. The results mark a significant step toward transforming early neurodevelopmental diagnostics.